|Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic|
C Hill, F Guarner, G Reid, GR Gibson, DJ Merenstein, B Pot, L Morelli, ...
Nature reviews Gastroenterology & hepatology 11 (8), 506-514, 2014
|Potential beneficial effects of butyrate in intestinal and extraintestinal diseases|
RB Canani, M Di Costanzo, L Leone, M Pedata, R Meli, A Calignano
World journal of gastroenterology: WJG 17 (12), 1519, 2011
|Scientific Opinion on Dietary Reference Values for carbohydrates and dietary fibre|
EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA)
EFSA journal 8 (3), 1462, 2010
|Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection|
M de Martino, PA Tovo, M Balducci, L Galli, C Gabiano, G Rezza, ...
Jama 284 (2), 190-197, 2000
|Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations|
RB Canani, P Cirillo, G Terrin, L Cesarano, MI Spagnuolo, A De Vincenzo, ...
Bmj 335 (7615), 340, 2007
|Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children|
RB Canani, P Cirillo, P Roggero, C Romano, B Malamisura, G Terrin, ...
Pediatrics 117 (5), e817-e820, 2006
|Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea|
A Guarino, RB Canani, MI Spagnuolo, F Albano, L Di Benedetto
Journal of pediatric gastroenterology and nutrition 25 (5), 516-519, 1997
|VSL# 3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study|
S Guandalini, G Magazzu, A Chiaro, V La Balestra, G Di Nardo, ...
Journal of pediatric gastroenterology and nutrition 51 (1), 24-30, 2010
|The epigenetic effects of butyrate: potential therapeutic implications for clinical practice|
RB Canani, M Di Costanzo, L Leone
Clinical epigenetics 4 (1), 4, 2012
|Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats|
E Esposito, A Iacono, G Bianco, G Autore, S Cuzzocrea, P Vajro, ...
The Journal of nutrition 139 (5), 905-911, 2009
|Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns|
G Terrin, A Passariello, M De Curtis, F Manguso, G Salvia, L Lega, ...
Pediatrics 129 (1), e40-e45, 2012
|Probiotics as prevention and treatment for diarrhea|
A Guarino, AL Vecchio, RB Canani
Current opinion in gastroenterology 25 (1), 18-23, 2009
|Epigenetic mechanisms elicited by nutrition in early life|
RB Canani, M Di Costanzo, L Leone, G Bedogni, P Brambilla, ...
Nutrition research reviews 24 (2), 198-205, 2011
|Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants|
RB Canani, N Sangwan, AT Stefka, R Nocerino, L Paparo, R Aitoro, ...
The ISME journal 10 (3), 742-750, 2016
|Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms|
A Iacono, GM Raso, RB Canani, A Calignano, R Meli
The Journal of nutritional biochemistry 22 (8), 699-711, 2011
|Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice|
RB Canani, L Rapacciuolo, MT Romano, LT De Horatio, G Terrin, ...
Digestive and Liver Disease 36 (7), 467-470, 2004
|Short-and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease|
RB Canani, G Terrin, O Borrelli, MT Romano, F Manguso, A Coruzzo, ...
Digestive and Liver Disease 38 (6), 381-387, 2006
|Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease|
RB Canani, G Terrin, L Rapacciuolo, E Miele, MC Siani, C Puzone, ...
Digestive and Liver Disease 40 (7), 547-553, 2008
|Scientific Opinion on nutrient requirements and dietary intakes of infants and young children in the European Union|
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
EFSA Journal 11 (10), 3408, 2013
|Response to infliximab is related to disease duration in paediatric Crohn's disease|
P Lionetti, F Bronzini, C Salvestrini, C Bascietto, RB Canani, ...
Alimentary pharmacology & therapeutics 18 (4), 425-431, 2003